Philogen SpA
MIL:PHIL

Watchlist Manager
Philogen SpA Logo
Philogen SpA
MIL:PHIL
Watchlist
Price: 19.1 EUR Market Closed
Market Cap: 558.5m EUR
Have any thoughts about
Philogen SpA?
Write Note

Wall Street
Price Targets

PHIL Price Targets Summary
Philogen SpA

Wall Street analysts forecast PHIL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHIL is 24.48 EUR with a low forecast of 23.23 EUR and a high forecast of 26.25 EUR.

Lowest
Price Target
23.23 EUR
22% Upside
Average
Price Target
24.48 EUR
28% Upside
Highest
Price Target
26.25 EUR
37% Upside
Philogen SpA Competitors:
Price Targets
IFRX
InflaRx NV
292% Upside
FOLD
Amicus Therapeutics Inc
85% Upside
DVYSR
Devyser Diagnostics AB
28% Upside
CDMO
Avid Bioservices Inc
6% Upside
4893
Noile-Immune Biotech Inc
181% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
58% Upside
BCRX
BioCryst Pharmaceuticals Inc
97% Upside
IONS
Ionis Pharmaceuticals Inc
75% Upside

Revenue
Forecast

Revenue Estimate
Philogen SpA

For the last 5 years the compound annual growth rate for Philogen SpA's revenue is 11%. The projected CAGR for the next 3 years is 64%.

11%
Past Growth
64%
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Philogen SpA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Net Income
Forecast

Net Income Estimate
Philogen SpA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHIL's stock price target?
Price Target
24.48 EUR

According to Wall Street analysts, the average 1-year price target for PHIL is 24.48 EUR with a low forecast of 23.23 EUR and a high forecast of 26.25 EUR.

What is Philogen SpA's Revenue forecast?
Projected CAGR
64%

For the last 5 years the compound annual growth rate for Philogen SpA's revenue is 11%. The projected CAGR for the next 3 years is 64%.

Back to Top